URINARY CRYSTAL-RENAL CELL INTERACTIONS IN UROLITHIASIS

尿石症中尿液晶体-肾细胞的相互作用

基本信息

  • 批准号:
    2134128
  • 负责人:
  • 金额:
    $ 8.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-01-01 至 1998-12-31
  • 项目状态:
    已结题

项目摘要

The candidate's long-term goal is to identify cellular and molecular mechanisms that mediate the early events in nephrolithiasis. The candidate and his sponsor, Dr. F. Gary Toback, have developed an educational plan which foster acquisition of the investigative skills and techniques necessary to conduct state-of-the-art research in renal cell physiology, and provides the opportunity to apply these studies directly to patients with nephrolithiasis. Development of the candidate into an independent investigator will be facilitated b receipt of a Clinical Investigator Award. During the course of the proposed award, he will expand previous collaborative efforts with established investigators in the basic sciences at the University of Chicago, as well as initiate new collaborations which extend his studies into new fields. The candidate will have the unique advantage of close contact with the University of Chicago Kidney Stone Program and a recognized expert in nephrolithiasis. During the past 2 1/2 years the candidate has developed a tissue culture model of nephrolithiasis and used it to characterize how renal epithelial cells respond to an interaction with the most common crystal in urine and stones, calcium oxalate monohydrate (COM). He found that COM crystals adhere to the renal cell surface, undergo endocytosis, and initiate subsequent cellular response such as early gene expression, cytoskeletal reorganization, and DNA synthesis. A novel observation, that Tamm-Horsfall glycoprotein (THP), the most abundant protein in human urine, inhibits endocytosis of COM crystals will be studied in depth because recent work reveals that this protein appears to have lost its inhibitory function in specific patients with recurrent nephrolithiasis. Specific aims of the project are to: 1) Define a specific surface receptor (s) for COM crystal on renal epithelial cells. 2) Characterize the interaction of THP with renal epithelial cells. 3) Investigate THP structure and function in patients with nephrolithiasis. 4) Define factors that regulate adhesin and subsequent endocytosis of COM crystals. 5) Identify structural and functional alteration in the plasma membrane, cytoskeleton, and nucleus of renal epithelial cells following attachment and endocytosis of COM crystals. 6) Determine if adhesion and/or endocytosis of COM crystals induces release of autocrine/paracrine factors from renal cells. 7)Identify potential therapeutic agents that block individual steps in the cascade of cellular and molecular events set in motion when a COM crystal interacts with a renal epithelial cell. Achieving these specific aims will increase understanding of how kidney epithelial cell respond to urinary crystals. Elucidation of these processes at the cellular and molecular level could help attain the long-term goal of formulating rational new therapeutic strategies to prevent renal crystal retention and the formation of calculi.
候选人的长期目标是识别细胞和 介导早期事件的分子机制, 肾结石 候选人和他的担保人F博士。加里 Toback,已经制定了一项教育计划, 进行调查所需的调查技能和技术 最先进的肾细胞生理学研究,并提供 有机会将这些研究直接应用于患者, 肾结石 将候选人发展为独立候选人 研究者将B收到临床 调查员奖。 在拟议的裁决过程中,他 将扩大以前的合作努力, 芝加哥大学的基础科学研究人员, 同时也开始了新的合作, 进入新的领域 候选人将拥有独特的优势, 与芝加哥大学肾结石项目密切联系 也是公认的肾结石专家 在过去的2 1/2 多年来,候选人已经开发了一个组织培养模型, 肾结石,并用它来描述肾上皮细胞如何 细胞对与最常见的晶体的相互作用做出反应, 尿和结石,草酸钙一水合物(COM)。 他发现 COM晶体粘附于肾细胞表面,进行内吞作用, 并启动随后的细胞反应,如早期基因 表达、细胞骨架重组和DNA合成。 一 新的观察,Tamm-Horsfall糖蛋白(THP),最 人尿中含有丰富的蛋白质,可抑制COM的内吞作用 晶体将被深入研究,因为最近的工作表明, 这种蛋白质似乎已经失去了抑制功能, 复发性肾结石的特殊患者。 具体目标 这些项目是:1)确定一种特定表面受体, 肾上皮细胞COM结晶。 2)表征 THP与肾上皮细胞的相互作用。 3)调查THP 肾结石患者肾组织结构和功能的变化。4)定义 调节粘附素和随后的COM内吞作用的因子 晶体 5)确定结构和功能的改变, 肾上皮细胞的质膜、细胞骨架和细胞核 细胞后的COM晶体的附着和内吞作用。 六、 确定COM晶体的粘附和/或内吞是否诱导 从肾细胞释放自分泌/旁分泌因子。 7)确定阻断单个步骤的潜在治疗药物 在细胞和分子事件的级联中, COM晶体与肾上皮细胞相互作用。 实现 这些特定的目标将增加对肾脏如何 上皮细胞对尿结晶有反应。 阐明这些 细胞和分子水平的过程可以帮助实现 制定合理的新治疗策略的长期目标 防止肾结晶滞留和结石形成。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(3)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John C Lieske其他文献

OSTEOPONTIN AND TAMM-HORSFALL PROTEIN ARE FUNCTIONALLY SYNERGISTIC IN PREVENTING RENAL CALCIFICATION
  • DOI:
    10.1016/s0022-5347(08)61661-4
  • 发表时间:
    2008-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Lan Mo;Lucy Liaw;Andrew P Evan;Andre J Sommer;John C Lieske;Xue-Ru Wu
  • 通讯作者:
    Xue-Ru Wu

John C Lieske的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John C Lieske', 18)}}的其他基金

Admin Core
管理核心
  • 批准号:
    10595344
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice
肾巨噬细胞在人类尿结石发病机制和小鼠兰德尔斑块形成中的作用
  • 批准号:
    10708970
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10708971
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Research Project
研究项目
  • 批准号:
    10708974
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice
肾巨噬细胞在人类尿结石发病机制和小鼠兰德尔斑块形成中的作用
  • 批准号:
    10595343
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Research Project
研究项目
  • 批准号:
    10595345
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
Improving stone disease treatment by accurate phenotyping and risk stratification
通过准确的表型分析和风险分层改善结石病的治疗
  • 批准号:
    9135351
  • 财政年份:
    2013
  • 资助金额:
    $ 8.83万
  • 项目类别:
Improving stone disease treatment by accurate phenotyping and risk stratification
通过准确的表型分析和风险分层改善结石病的治疗
  • 批准号:
    8598968
  • 财政年份:
    2013
  • 资助金额:
    $ 8.83万
  • 项目类别:
Improving stone disease treatment by accurate phenotyping and risk stratification
通过准确的表型分析和风险分层改善结石病的治疗
  • 批准号:
    9343372
  • 财政年份:
    2013
  • 资助金额:
    $ 8.83万
  • 项目类别:
Genetic determinants of urine lithogenicity
尿液成石性的遗传决定因素
  • 批准号:
    7920691
  • 财政年份:
    2009
  • 资助金额:
    $ 8.83万
  • 项目类别:

相似海外基金

Discovery of cell membrane permeable HDAC6 PROTACs
细胞膜渗透性 HDAC6 PROTAC 的发现
  • 批准号:
    23K06061
  • 财政年份:
    2023
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Control of cell membrane permeability by intense electrical pulses and development of innovative food processing
通过强电脉冲控制细胞膜渗透性和创新食品加工的发展
  • 批准号:
    23H01403
  • 财政年份:
    2023
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a method to inhibit epithelial-mesenchymal transition by targeting cell membrane phospholipids
开发一种通过靶向细胞膜磷脂抑制上皮间质转化的方法
  • 批准号:
    23K06103
  • 财政年份:
    2023
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Host cell membrane perforation during invasion by Toxoplasma gondii
弓形虫入侵过程中宿主细胞膜穿孔
  • 批准号:
    10587658
  • 财政年份:
    2023
  • 资助金额:
    $ 8.83万
  • 项目类别:
Cell membrane-targeting proteoglycan chimeras as selective growth factor signaling actuators
作为选择性生长因子信号传导执行器的细胞膜靶向蛋白聚糖嵌合体
  • 批准号:
    10588085
  • 财政年份:
    2023
  • 资助金额:
    $ 8.83万
  • 项目类别:
High throughput antibody discovery against cell membrane bound target proteins using innovative MOD technology for direct screening in single-cell assays
使用创新的 MOD 技术发现针对细胞膜结合靶蛋白的高通量抗体,用于单细胞测定中的直接筛选
  • 批准号:
    10698891
  • 财政年份:
    2023
  • 资助金额:
    $ 8.83万
  • 项目类别:
Probing the specific interactions of AlphaA- crystallin and its aging- and cataract-associated forms with lens cell membrane mimics
探讨 AlphaA-晶状体蛋白及其与衰老和白内障相关的形式与晶状体细胞膜模拟物的特定相互作用
  • 批准号:
    10667060
  • 财政年份:
    2023
  • 资助金额:
    $ 8.83万
  • 项目类别:
Three-dimensional measurement of cell-sercreted molecules using probe-type artificial cell membrane systems
使用探针型人工细胞膜系统对细胞分泌分子进行三维测量
  • 批准号:
    23H01822
  • 财政年份:
    2023
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
An extedned research of cell membrane domains based on the probes of membrane molecules
基于膜分子探针的细胞膜域扩展研究
  • 批准号:
    22H00359
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Nanostructure transfer to cell membrane by cytoplasmic gelation and its optical sensor application
细胞质凝胶化纳米结构转移至细胞膜及其光学传感器应用
  • 批准号:
    22K18760
  • 财政年份:
    2022
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了